Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells
Open accessThe DOI matches its Crossref record; 210 of the 210 references it cites were found in a registry or an index; 45 of the 212 sources its claims cite were checked for support.
Abstract
Bone tissue is continuously remodeled through the concerted actions of bone cells, which include bone resorption by osteoclasts and bone formation by osteoblasts, whereas osteocytes act as mechanosensors and orchestrators of the bone remodeling process. This process is under the control of local (e.g., growth factors and cytokines) and systemic (e.g., calcitonin and estrogens) factors that all together contribute for bone homeostasis. An imbalance between bone resorption and formation can result in bone diseases including osteoporosis. Recently, it has been recognized that, during bone remodeling, there are an intricate communication among bone cells. For instance, the coupling from bone resorption to bone formation is achieved by interaction between osteoclasts and osteoblasts. Moreover, osteocytes produce factors that influence osteoblast and osteoclast activities, whereas osteocyte apoptosis is followed by osteoclastic bone resorption. The increasing knowledge about the structure and functions of bone cells contributed to a better understanding of bone biology. It has been suggested that there is a complex communication between bone cells and other organs, indicating the dynamic nature of bone tissue. In this review, we discuss the current data about the structure and functions of bone cells and the factors that influence bone remodeling.
Overview
CoChat Summary
TL;DR
This narrative review summarizes bone tissue biology, focusing on the structure and functions of osteoblasts, bone lining cells, osteocytes, and osteoclasts, the extracellular matrix, and local/systemic regulators of bone remodeling. It emphasizes cell–cell coupling, osteocyte mechanosensing, estrogen’s role, and emerging endocrine functions of bone.
Key findings
- Bone contains four cell types: osteoblasts (4–6% of total resident bone cells) form bone; osteocytes (90–95% of total bone cells, lifespan up to 25 years) act as mechanosensors and orchestrators; osteoclasts resorb bone; bone lining cells participate in coupling and the basic multicellular unit.
- The osteocyte lacunocanalicular system includes up to 50 cytoplasmic processes per cell; osteocyte surface is estimated to be 400-fold larger than all Haversian and Volkmann systems and more than 100-fold larger than trabecular bone surface; the lacunar space is about 0.5–1.0 μm wide and the canalicular membrane distance is 50–100 nm.
- Bone remodeling proceeds through initiation of resorption, a transition/reversal phase, and bone formation; coupling involves matrix-released factors such as IGFs, TGF-β, BMPs, FGF, and PDGF, plus semaphorins (Sema4D, Sema3A) and ephrinB2/EphB4, while imbalance can cause osteoporosis or osteopetrosis.
- Estrogen maintains bone homeostasis by inhibiting osteoblast and osteocyte apoptosis, suppressing osteoclast formation/activity, inducing osteoclast apoptosis, and modulating RANKL/OPG and cytokines; bone endocrine actions include undercarboxylated osteocalcin effects on pancreas, adipose tissue, testis, and brain, and osteocyte FGF23 regulation of phosphate metabolism.
Methods
- Design: narrative review; the authors state they discuss current data about bone cells, bone matrix, factors influencing bone remodeling, and estrogen under physiological and pathological conditions.
- Data or sample: no primary sample or dataset; evidence is drawn from cited in vitro and in vivo studies and prior literature.
- Main analysis: narrative synthesis of structural, molecular, and functional findings; no systematic search, meta-analysis, or new experiments are reported.
Limitations
- Stated in the paper: bone lining cell functions are not completely understood; mechanisms of osteocyte mechanosensing and the precise osteocyte-derived osteoclastogenesis-stimulating factors remain uncertain; direct in vivo contact between mature osteoblasts and osteoclasts has not been demonstrated and is controversial; bone endocrine function is still poorly understood.
- Evident from the text: as a narrative review, it lacks a systematic search strategy, risk-of-bias assessment, or quantitative synthesis, and its conclusions depend on the selected cited literature.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
23 Valid · 2 Not valid · 92 Not checked · 16 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“For instance, in bones subjected to fatigue loading, viable osteocytes near the apoptotic ones express, besides high RANKL/OPG ratio, increased levels of vascular endothelial growth factor (VEGF) and monocyte chemoattractant protein-1 (CCL2) promoting an increase in local osteoclastogenesis [194, 195].”
§ Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells > 2. Bone Cells > 2.8. Bone Remodeling Process
What the sources say
- Partly supportedcites [194] matched to “Activation of resorption in fatigue-loaded bone involves both apoptosis and active pro-osteoclastogenic signaling by distinct osteocyte populations” (2012) sourceExperimental — accuracy not yet measured
Kennedy et al. (2012) support most of the sentence: the Abstract (p.1) and Results > Immunohistochemistry show RANKL and VEGF staining peaking 100-300 um from the damage site in non-apoptotic osteocytes while caspase-3+ cells dominate the damage core, and the Discussion states the RANKL/OPG ratio shift 'favoring osteoclast formation'. However, the candidate genes and IHC targets were only RANKL, OPG, VEGF and M-CSF (Materials and Methods > Gene expression analyses; Results > Gene expression) - CCL2/MCP-1 is neither measured nor mentioned anywhere in our copy (searched: CCL2, monocyte chemoattractant protein-1, MCP-1, chemokine), so that part of the claim is not attributable to this source. Also, the pro-osteoclastogenic conclusion is inferred from signaling patterns, since tissues were analyzed 3 and 7 days after fatigue, 'prior to the first appearance of osteoclasts'. (LLM, conf=0.85)
- Disputedcites [195] matched to “MCP-1 Expression Is Specifically Regulated During Activation of Skeletal Repair and Remodeling” (2013) sourceExperimental — accuracy not yet measured
Our copy places CCL2/MCP-1 expression in osteoblasts, not osteocytes: the Abstract reports that by in-situ hybridization and immunohistochemistry 'MCP-1 mRNA and protein was localized in periosteal osteoblasts associated with woven bone formation at the fracture exit point, but not within osteocytes adjacent to the SFx', and the Discussion likewise concludes MCP-1 is secreted by osteoblasts as a candidate signal attracting osteoclasts and their precursors. The paper's model is rat ulnar stress fracture initiation by cyclic end-loading, and it explicitly contrasts this with 'adaptive' ulnar loading; nowhere does our copy report viable osteocytes near apoptotic ones, nor any measurement of VEGF or of a high RANKL/OPG ratio in osteocytes (RANKL/OPG appears only as a downstream pathway shared with gp-130 cytokines such as IL-6/IL-11, Discussion). Thus the cellular source and the VEGF/RANKL-OPG components attributed to this source are contrary to, or absent from, our copy. (LLM, conf=0.80)
Checked by a reasoning model — may be wrong.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
None of the sources cited for this claim have been checked yet.
In the paper
“Bone lining cells functions are not completely understood, but it has been shown that these cells prevent the direct interaction between osteoclasts and bone matrix, when bone resorption should not occur, and also participate in osteoclast differentiation, producing osteoprotegerin (OPG) and the receptor activator of nuclear factor kappa-B ligand (RANKL) [14, 53].”
§ Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells > 2. Bone Cells > 2.2. Bone Lining Cells
What the sources say
- Could not verifycites [14] matched to “A Physical Mechanism for Coupling Bone Resorption and Formation in Adult Human Bone” (2009) sourceExperimental — accuracy not yet measured
The Discussion describes bone-lining cells as poorly characterized and suggests they may be early osteoblast-lineage cells. It separately suggests that osteoblast precursors near differentiating pre-osteoclasts may express RANKL, but does not identify those precursors as bone-lining cells or say that bone-lining cells produce OPG. Searches for bone-lining cells with OPG, RANKL, and osteoclast differentiation found no passage establishing the claim. (LLM, conf=0.73)
- Not checked yetcites [53] 2000, Journal of Rehabilitation Research and Development
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Moreover, osteocyte apoptosis has been recognized as a chemotactic signal to osteoclastic bone resorption [70–73].”
§ Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells > 2. Bone Cells > 2.3. Osteocytes
What the sources say
- Not checked yetcites [70] matched to “Identification of apoptotic changes in osteocytes in normal and pathological human bone” (1997) source
- Not checked yetcites [71] matched to “Osteocyte apoptosis is induced by weightlessness in mice and precedes osteoclast recruitment and bone loss.” (2006) source
- Supportedcites [72] matched to “Apoptotic Osteocytes and the Control of Targeted Bone Resorption” (2014) source
The section on osteocyte apoptosis and osteoclast recruitment states that apoptotic osteocytes recruit osteoclasts to initiate bone resorption. It also identifies HMGB1, released by apoptotic osteocytic cells, as chemotactic for osteoclasts, while noting that the signals responsible in vivo remain to be identified. (LLM, conf=0.86)
- Supportedcites [73] matched to “Osteocyte-Driven Bone Remodeling” (2014) source
In section 3, “Dying osteocytes,” the review says apoptotic osteocytes precede resorption and may act as beacons for osteoclast recruitment. It also describes a potential chemotactic factor released during osteocyte apoptosis. The claim reflects that proposed link without identifying a specific signal. (LLM, conf=0.91)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“Other recent evidence is that osteoclasts may also directly regulate the hematopoietic stem cell niche [112].”
§ Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells > 2. Bone Cells > 2.4. Osteoclasts
What the sources say
- Supportedcites [112] matched to “Osteoclasts: more than ‘bone eaters’” (2014) source
The HSC-niche section says osteoclasts may directly regulate the hematopoietic stem cell niche. The Concluding Remarks repeat this qualified claim while noting that conflicting reports remain to be resolved. (LLM, conf=0.95)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The systemic factors which are important to the maintenance of bone homeostasis include parathyroid hormone (PTH), calcitonin, 1,25-dihydroxyvitamin D3 (calcitriol), glucocorticoids, androgens, and estrogens [16, 147–150].”
§ Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells > 2. Bone Cells > 2.7. Local and Systemic Factor That Regulate Bone Homeostasis
What the sources say
- Partly supportedcites [16] matched to “Estrogen and the skeleton” (2012) sourceExperimental — accuracy not yet measured
Our copy supports only the sex-steroid part of the attributed list: the Overview of estrogen action on bone states that 'estrogen is perhaps the major systemic regulator of bone metabolism not only in women, but also in men,' and the same section (citing Falahati-Nini et al., ref 5) and ref 31 address androgens/testosterone as systemic bone regulators. The other four factors named in the claim — parathyroid hormone, calcitonin, 1,25-dihydroxyvitamin D3 (calcitriol) and glucocorticoids — appear nowhere in our copy (searched: 'systemic factors parathyroid hormone calcitonin 1,25-dihydroxyvitamin D glucocorticoids', 'parathyroid hormone', 'calcitonin', 'glucocorticoids calcitonin vitamin D androgens'); every returned passage concerned estrogen actions, coupling factors in the bone remodeling compartment, or the reference list. Thus the paper does not enumerate the systemic hormonal repertoire the citing sentence attributes to it. (LLM, conf=0.72)
- Partly supportedcites [147] matched to “Activated parathyroid hormone/parathyroid hormone–related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone” (2001) sourceExperimental — accuracy not yet measured
The Introduction (p. 1) of Calvi et al. 2001 supports only the PTH element of the list: it describes PTH as 'a major regulator of calcium homeostasis' that 'plays an important role in both bone formation and resorption' in the context of factors controlling osteoblast/osteoclast balance. Our copy nowhere mentions calcitonin, 1,25-dihydroxyvitamin D3 (calcitriol), glucocorticoids, androgens, or estrogens as systemic factors maintaining bone homeostasis (searched: calcitonin; estrogen/glucocorticoid/systemic hormonal regulators; 1,25-dihydroxyvitamin D3), so the remaining five items attributed to this source are unsupported. The paper's scope is the local action of activated PTH/PTHrP receptor in osteoblastic cells on cortical versus trabecular bone in transgenic mice, not a survey of systemic hormonal regulators. (LLM, conf=0.72)
- Not checked yetcites [148] 2002, BMC Musculoskeletal Disorders
- Not checked yetcites [149] matched to “Forty years of calcitonin—where are we now? A tribute to the work of Iain Macintyre, FRS” (2002) source
- Not checked yetcites [150] matched to “Androgens and Bone” (2004) source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
81 more claims · 12 with their cited sources checked
Create a free account to see all 133 claims and to verify the 167 references still open.
- It may state two separate claims as one. 40
- Probably not a substantial claim. 11
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In vivo, a set of osteoblasts, all with similar morphologies, lay down osteoid on active bone-forming surfaces.268”
From Bone remodeling: an operational process ensuring survival and bone mechanical competence (2022) · cites this paper as [268]
Citations
Cites
Stöckl, S., Göttl, C., Grifka, J., & Grässel, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350089 · Cited by 4,656
Osf2/Cbfa1: A Transcriptional Activator of Osteoblast Differentiation
Ducy, P., Zhang, R., Geoffroy, V., Ridall, A. L., & Karsenty, G. (1997) · Cell · doi:10.1016/s0092-8674(00)80257-3 · Cited by 4,246 · cited 2×
“The expressions of Runtrelated transcription factors 2,Distal-less homeobox 5 (Dlx5), and osterix (Osx) are crucial for osteoblast differentiation [22, 26].”
BackgroundKomori, T., Yagi, H., Nomura, S., Yamaguchi, A., Sasaki, K., Deguchi, K., Shimizu, Y., Bronson, R. T., Gao, Y.-H., Inada, M., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80258-5 · Cited by 4,244
Nakashima, K., Zhou, X., Kunkel, G., Zhang, Z., Deng, J. M., Behringer, R. R., & de Crombrugghe, B. (2002) · Cell · doi:10.1016/s0092-8674(01)00622-5 · Cited by 3,608
Manolagas, S. C. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.2.0395 · Cited by 2,568
Bonewald, L. F. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.320 · Cited by 2,287 · cited 3×
“Besides osteoclasts and osteoblasts, it has been demonstrated that osteocytes play key roles during the bone remodeling cycle [8].”
BackgroundNormal Bone Anatomy and Physiology
Clarke, B. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04151206 · Cited by 2,192
Bone Quality — The Material and Structural Basis of Bone Strength and Fragility
Seeman, E., & Delmas, P. D. (2006) · New England Journal of Medicine · doi:10.1056/nejmra053077 · Cited by 2,080
Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems
Takayanagi, H. (2007) · Nature Reviews Immunology · doi:10.1038/nri2062 · Cited by 1,878 · cited 2×
“Together, these factors promote the activation of transcription factors [81, 82] and gene expression in osteoclasts [83, 84].”
BackgroundFunctions of RANKL/RANK/OPG in bone modeling and remodeling
Boyce, B. F., & Xing, L. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.03.018 · Cited by 1,844 · cited 1×
“On the other hand, another factor called osteoprotegerin (OPG), which is produced by a wide range of cells including osteoblasts, stromal cells, and gingival and periodontal fibroblasts [87–89], binds to RANKL, preventing the RANK/RANKL interaction and, consequently, inhibiting the osteoclastogenesis [87] (Figure 5).”
Background
Research works printed but not linked: 15
- 2004, Histology and Histopathology, 19, 1325
- 1998, The nature of the mineral phase in bone, 23
- 1990, Bone-forming cells in clinical conditions, 351
- 1989, Scanning Microscopy, 3, 953
- 2000, Journal of Rehabilitation Research and Development, 37, 189
- 1999, The FASEB Journal, 13, S101
- 1999, Laboratory Investigation, 79, 83
- 2008, Journal of Musculoskeletal Neuronal Interactions, 8, 204
- 2005, Journal of Musculoskeletal Neuronal Interactions, 5, article 316
- 1972, Bone resorption and matrix hexosamine labeling, 327
- 2008, Integrins and adhesion molecules, 385
- 2004, Anatomical Record Part A: Discoveries in Molecular, Cellular, and Evolutionary Biology, 278, 505
- 2002, BMC Musculoskeletal Disorders, 7, 3
- 1997, Endocrine Society Journals and Publications, 82, 3128
- 2006, Journal of Musculoskeletal Neuronal Interactions, 6, 354
Cited by
Items 401–500 of 1,003
Manivasagam, V. K., & Popat, K. C. (2021) · Materials Science and Engineering C · doi:10.1016/j.msec.2021.112315 · Cited by 38
Hydrogel: A Potential Material for Bone Tissue Engineering Repairing the Segmental Mandibular Defect
Maruf, D. S. A. A., Ghosh, Y. A., Xin, H., Cheng, K., Mukherjee, P., Crook, J. M., Wallace, G. G., Klein, T. J., & Clark, J. R. (2022) · Polymers · doi:10.3390/polym14194186 · Cited by 38
Geopolymer Materials for Bone Tissue Applications: Recent Advances and Future Perspectives
Ricciotti, L., Apicella, A. M., Perrotta, V., & Aversa, R. M. (2023) · Polymers · doi:10.3390/polym15051087 · Cited by 38
Boulanger‐Piette, A., Hamoudi, D., Marcadet, L., Morin, F., Argaw, A., Ward, L. M., & Frenette, J. (2018) · Current Osteoporosis Reports · doi:10.1007/s11914-018-0468-2 · Cited by 38
Yuan, X., Wu, T., Lu, T., & Ye, J. (2023) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.3c00193 · Cited by 37
Proteoglycans in mechanobiology of tissues and organs: Normal functions and mechanopathology
Farach‐Carson, M. C., Wu, D., & França, C. M. (2024) · Proteoglycan Research · doi:10.1002/pgr2.21 · Cited by 37
Heimann, R. B. (2024) · Coatings · doi:10.3390/coatings14070787 · Cited by 37
Dempsey, N., & Blau, S. (2020) · Forensic Science International · doi:10.1016/j.forsciint.2020.110140 · Cited by 37
Antioxidant Strategy to Prevent Simulated Microgravity-Induced Effects on Bone Osteoblasts
Morabito, C., Guarnieri, S., Cucina, A., Bizzarri, M., & Mariggiò, M. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103638 · Cited by 37
Hughes, A. M., Kolb, A. D., Shupp, A. B., Shine, K. M., & Bussard, K. M. (2021) · Cancers · doi:10.3390/cancers13030507 · Cited by 37
Biomaterials-based bioengineering strategies for bioelectronic medicine
Panda, A. K., & Basu, B. (2021) · Materials Science and Engineering R Reports · doi:10.1016/j.mser.2021.100630 · Cited by 37
Wang, D., Steffi, C., Wang, Z., Kong, C. H., Lim, P. N., Shi, Z., Thian, E. S., & Wang, W. (2018) · Nanoscale · doi:10.1039/c8nr05268a · Cited by 37
Sieger, D., Koržinskas, T., Jung, O., Stojanović, S., Wenisch, S., Smeets, R., Gosau, M., Schnettler, R., Najman, S. J., & Barbeck, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081969 · Cited by 37
Tan, X. H., Liu, L., Mitryashkin, A., Wang, Y., & Goh, J. C. H. (2022) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.2c00313 · Cited by 36
Emerging role of liver-bone axis in osteoporosis
Gao, H., Peng, X., Li, N., Gou, L., Xu, T., Wang, Y., Qin, J., Liang, H., Ma, P., Li, S., et al. (2024) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2024.07.008 · Cited by 36
“During human growth and development, bone needs continuous and dynamic remodeling to adapt to body changes [5].”
BackgroundSilva-Barroso, A. S., Cabral, . S. D., Ferreira, P. C. N., Moreira, A. F., & Correia, I. J. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.124258 · Cited by 36
Nanoceramics-reinforced chitosan scaffolds in bone tissue engineering
Harini, G., Bharathi, R., Sankaranarayanan, A., Shanmugavadivu, A., & Selvamurugan, N. (2023) · Materials Advances · doi:10.1039/d3ma00422h · Cited by 36
Yun, C., Kim, S. H., Kim, K. M., Yang, M. H., Byun, M. R., Kim, J., Kwon, D., Pham, H. T. M., Kim, H.-S., Kim, J.-H., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052512 · Cited by 36
Chen, J., Kuang, S., Cen, J., Zhang, Y., Shen, Z., Qin, W., Huang, Q., Wang, Z., Gao, X., Huang, F., et al. (2024) · International Journal of Oral Science · doi:10.1038/s41368-024-00309-9 · Cited by 36
Principles of musculoskeletal sport injuries for epidemiologists: a review
Wang, C., Stovitz, S. D., Kaufman, J. S., Steele, R. J., & Shrier, I. (2024) · Injury Epidemiology · doi:10.1186/s40621-024-00507-3 · Cited by 36
From death to birth: how osteocyte death promotes osteoclast formation
Zhao, W., Qian, J., Li, J., Su, T., Deng, X., Fu, Y., Liang, X., & Cui, H. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1551542 · Cited by 36
Vicaş, R. M., Bodog, F. D., Fugaru, F. O., Grosu, F., Badea, O., Lazăr, L., Cevei, M. L., Nistor-Cseppento, C. D., Beiuşanu, G. C., Holt, G., et al. (2021) · Romanian Journal of Morphology and Embryology · doi:10.47162/rjme.61.4.26 · Cited by 36
Shi, L., Hong, G., Chen, C., Li, X., Zhang, H., Chai, R., & Sun, D. (2023) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2023.120749 · Cited by 36
Palavenienė, A., Tamburacı, S., Kımna, C., Glambaitė, K., Baniukaitienė, O., Tıhmınlıoğlu, F., & Liesienė, J. (2018) · Journal of Biomaterials Applications · doi:10.1177/0885328218811040 · Cited by 36
Chen, X., Cheng, Y., & Wu, H. (2023) · Ceramics International · doi:10.1016/j.ceramint.2023.03.109 · Cited by 35
Gradient scaffolds for osteochondral tissue engineering and regeneration
Xiong, Z., Hong, F., Wu, Z., Ren, Y., Sun, N., Heng, B. C., & Zhou, J. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.154797 · Cited by 35
Bone Substitutes in Orthopaedic Surgery: Current Status and Future Perspectives
Busch, A., Wegner, A., Haversath, M., & Jäger, M. (2020) · Zeitschrift für Orthopädie und Unfallchirurgie · doi:10.1055/a-1073-8473 · Cited by 35
The Link Between Bone Osteocalcin and Energy Metabolism in a Group of Postmenopausal Women.
Dumitru, N., Carşote, M., Cocolos, A. M., Petrova, E. N., Olaru, M. L., Dumitrache, C., & Ghemigian, A. M. (2019) · PubMed Central · doi:10.12865/chsj.45.01.06 · Cited by 35
The functions of mechanosensitive ion channels in tooth and bone tissues
Pei, F., Liu, J., Zhang, L., Pan, X., Huang, W., Cen, X. B., Huang, S., Jin, Y. H., & Zhao, Z. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109877 · Cited by 35
Lee, A., Yang, H. J., Kim, T. S., Ha, H., & Hwang, Y. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112300 · Cited by 35
Comparison of Necroptosis With Apoptosis for OVX-Induced Osteoporosis
He, B., Zhu, Y., Cui, H., Sun, B., Su, T., & Wen, P. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.790613 · Cited by 35
Inhibition of Cdk5 increases osteoblast differentiation and bone mass and improves fracture healing
Ahmad, M., Krüger, B. T., Kroll, T. C., Vettorazzi, S., Dorn, A.-K., Mengele, F., Lee, S., Nandi, S., Yilmaz, D., Stolz, M., et al. (2022) · Bone Research · doi:10.1038/s41413-022-00195-z · Cited by 35
MiR-181a-5p promotes osteogenesis by targeting BMP3
Long, Z., Dou, P., Cai, W., Mao, M., & Wu, R. (2023) · Aging · doi:10.18632/aging.204505 · Cited by 35
Yin, P., Chen, M., Rao, M., Lin, Y., Zhang, M., Xu, R., Hu, X., Chen, R., Chai, W., Huang, X., et al. (2023) · Advanced Science · doi:10.1002/advs.202304084 · Cited by 35
Morse, A., Schindeler, A., McDonald, M. M., Kneissel, M., Krämer, I., & Little, D. G. (2017) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3330 · Cited by 35
Iguchi, M., Hiroi, M., Kanegae, H., & Ohmori, Y. (2018) · Mediators of Inflammation · doi:10.1155/2018/3979606 · Cited by 35
Loss of KDM4B impairs osteogenic differentiation of OMSCs and promotes oral bone aging
Deng, P., Chang, I., Wang, J., Badreldin, A. A., Li, X., Yu, B., & Wang, C. (2022) · International Journal of Oral Science · doi:10.1038/s41368-022-00175-3 · Cited by 34
Recent advances in metal-based nanomaterials for malignant bone tumor therapy
Liu, W., Guo, M., Hu, Y., Chen, Y., Wang, Y., Nezamzadeh‐Ejhieh, A., Lu, C., Lu, C., & Liu, J. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117427 · Cited by 34
Eleniste, P. P., Patel, V., Posritong, S., Aguirre‐Zero, O., Largura, H. W., Cheng, Y., Himes, E. R., Hamilton, M., Ekwealor, J. T. B., Kacena, M. A., et al. (2015) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25430 · Cited by 34
Sumathra, M., Munusamy, M. A., Alarfaj, A. A., & Rajan, M. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.04.078 · Cited by 34
Bellucci, D., Veronesi, E., Strusi, V., Petrachi, T., Murgia, A., Mastrolia, I., Dominici, M., & Cannillo, V. (2019) · Materials · doi:10.3390/ma12213633 · Cited by 34
Reengineering Bone-Implant Interfaces for Improved Mechanotransduction and Clinical Outcomes
Melo-Fonseca, F., Miranda, G., Domingues, H. S., Pinto, I. M., Gasik, M. I., & Silva, F. S. (2020) · Stem Cell Reviews and Reports · doi:10.1007/s12015-020-10022-9 · Cited by 34
Guerrieri, A. N., Montesi, M., Sprio, S., Laranga, R., Mercatali, L., Tampieri, A., Donati, D. M., & Lucarelli, E. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.589964 · Cited by 34
Role of FGF-18 in Bone Regeneration
Murugaiyan, K., Amirthalingam, S., Hwang, N. S.-Y., & Jayakumar, R. (2023) · Journal of Functional Biomaterials · doi:10.3390/jfb14010036 · Cited by 34
Research progress of the mechanisms and applications of ginsenosides in promoting bone formation
Li, Z., Li, Y., Liu, C., Gu, Y., & Han, G. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155604 · Cited by 34
Erythropoietin in bone – Controversies and consensus
Hiram‐Bab, S., Neumann, D., & Gabet, Y. (2016) · Cytokine · doi:10.1016/j.cyto.2016.01.008 · Cited by 34
Rictor/mTORC2 loss in osteoblasts impairs bone mass and strength
Liu, D., Zhao, L., Liu, T., Jiao, P.-L., Zhao, D., Shih, M., Tao, B., Sun, L., Zhao, H., & Liu, J. (2016) · Bone · doi:10.1016/j.bone.2016.05.010 · Cited by 34
Saraiva, J. A., da Fonseca, T. S., da Silva, G. F., Sasso‐Cerri, E., Guerreiro‐Tanomaru, J. M., Tanomaru‐Filho, M., & Cerri, P. S. (2017) · Biomedical Materials · doi:10.1088/1748-605x/aaa1f5 · Cited by 34
Self-citationSteffi, C., Shi, Z., Kong, C. H., Chong, S. W., Wang, D., & Wang, W. (2019) · Polymers · doi:10.3390/polym11081256 · Cited by 34
Cai, W., Huo, Y., Liu, Y., Su, Y., Guo, H., Wang, L., Li, B., & Liang, T. (2025) · EngMedicine · doi:10.1016/j.engmed.2025.100057 · Cited by 33
Arora, H., Shang, N., Bhullar, K. S., & Wu, J. (2020) · Food & Function · doi:10.1039/d0fo00497a · Cited by 33
Strategies for transdermal drug delivery against bone disorders: A preclinical and clinical update
Sharma, G., Alle, M., Chakraborty, C., & Kim, J. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.06.035 · Cited by 33
Campodoni, E., Montanari, M., Artusi, C., Bassi, G., Furlani, F., Montesi, M., Panseri, S., Sandri, M., & Tampieri, A. (2021) · Journal of Composites Science · doi:10.3390/jcs5100278 · Cited by 33
Li, D., Jiang, Y., He, P., Li, Y., Wu, Y., Lei, W., Liu, N., de Bruijn, J. D., Zhang, H., Zhang, H., et al. (2023) · Advanced Science · doi:10.1002/advs.202207224 · Cited by 33
From the Mind to the Spine: The Intersecting World of Alzheimer’s and Osteoporosis
Margetts, T. J., Wang, H. S., Karnik, S. J., Plotkin, L. I., Movilă, A., Oblak, A. L., Fehrenbacher, J. C., & Kacena, M. A. (2024) · Current Osteoporosis Reports · doi:10.1007/s11914-023-00848-w · Cited by 33
de Oliveira, P. A., Júnior, J. P. D. P., Longhini, R., Sasso‐Cerri, E., & Cerri, P. S. (2016) · Journal of Periodontology · doi:10.1902/jop.2016.160132 · Cited by 33
Self-citationAn update on the Application of Nanotechnology in Bone Tissue Engineering
Griffin, M., Kalaskar, D. M., Seifalian, A. M., & Butler, P. E. M. (2016) · The Open Orthopaedics Journal · doi:10.2174/1874325001610010836 · Cited by 33
Mizerska-Kowalska, M., Sławińska-Brych, A., Kaławaj, K., Żurek, A., Pawińska, B., Rzeski, W., & Zdzisińska, B. (2019) · Molecules · doi:10.3390/molecules24142637 · Cited by 33
Saleh, S. R., Saleh, O. M., El-Bessoumy, A. A., Sheta, E., Ghareeb, D. A., & Eweda, S. M. (2024) · Antioxidants · doi:10.3390/antiox13010066 · Cited by 32
Oral microbiota–host interaction: the chief culprit of alveolar bone resorption
Xu, J., Yu, L., Ye, S., Ye, Z., Yang, L., & Xu, X. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1254516 · Cited by 32
Arya, P. N., Saranya, I., & Selvamurugan, N. (2024) · Differentiation · doi:10.1016/j.diff.2024.100803 · Cited by 32
Lee, K. I.-R., Chen, J.-H., & Chen, K.-H. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27020641 · Cited by 32
Ibrahim, A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-08-101103-4.00015-6 · Cited by 37
Haversian bone-mimicking bioceramic scaffolds enhancing MSC-macrophage osteo-imunomodulation
Zhang, B., Zhang, M., Sun, Y., Li, M., Han, F., & Wu, C. (2021) · Progress in Natural Science Materials International · doi:10.1016/j.pnsc.2021.04.008 · Cited by 32
Rat Calvarial Bone Regeneration by 3D-Printed Beta-Tricalcium Phosphate Incorporating MicroRNA-200c
Remy, M. T., Akkouch, A., Li, H., Eliason, S. L., Sweat, M., Krongbaramee, T., Fei, F., Qian, F., Amendt, B. A., Song, X., et al. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c01756 · Cited by 32
Hellicar, J., Stevenson, N. L., Stephens, D. J., & Lowe, M. (2022) · Journal of Cell Science · doi:10.1242/jcs.258879 · Cited by 32
Poleboina, S., Sheth, V. G., Sharma, N., Sihota, P., Kumar, N., & Tikoo, K. (2022) · Nanomedicine · doi:10.2217/nnm-2021-0401 · Cited by 32
Marcello, F. D., Donato, G. D., d’Angelo, D. M., Breda, L., & Chiarelli, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105725 · Cited by 32
Effects of polyphenols and their metabolites on age-related diseases
Chouari, Z., Lounis, W., Ghzaiel, I., Kessas, K., Zarrouk, A., Ksila, M., Ghrairi, T., Latruffe, N., Masmoudi‐Kouki, O., Midaoui, A. E., et al. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115674 · Cited by 32
Intersecting Paths: Unraveling the Complex Journey of Cancer to Bone Metastasis
Arakil, N., Akhund, S. A., Elaasser, B., & Mohammad, K. S. (2024) · Biomedicines · doi:10.3390/biomedicines12051075 · Cited by 32
Osteoporosis and Alzheimer´s disease (or Alzheimer´s disease and Osteoporosis)
Wanionok, N. E., Morel, G. R., & Fernández, J. M. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102408 · Cited by 32
Júnior, J. P. D. P., Sasso‐Cerri, E., & Cerri, P. S. (2018) · Cells · doi:10.3390/cells7110206 · Cited by 32
Self-citationThe role of nervous system in adaptive response of bone to mechanical loading
Qiao, Y., Wang, Y., Zhou, Y., Jiang, F., Huang, T., Chen, L., Lan, J., Yang, C., Guo, Y., Yan, S., et al. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27683 · Cited by 32
Raić, A., Friedrich, F., Kratzer, D., Bieback, K., Lahann, J., & Lee‐Thedieck, C. (2019) · Scientific Reports · doi:10.1038/s41598-019-56508-6 · Cited by 32
Arab, M., Behboodi, P., Khachatourian, A. M., & Nemati, A. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e33847 · Cited by 31
Elango, J., Saravanakumar, K., Rahman, S. U., Henrotin, Y. E., Regenstein, J. M., Wu, W., & Bao, B. (2019) · Biomolecules · doi:10.3390/biom9050173 · Cited by 31
Martín‐Guerrero, E., Tirado‐Cabrera, I., Buendía, I., Alonso, V., Gortázar, A. R., & Ardura, J. A. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29636 · Cited by 31
Biomechanical Study of Proximal Femur for Designing Stems for Total Hip Replacement
Solórzano-Requejo, W., Ojeda, C., & Lantada, A. D. (2020) · Applied Sciences · doi:10.3390/app10124208 · Cited by 31
Vitamin K and D Supplementation and Bone Health in Chronic Kidney Disease—Apart or Together?
Ziemińska, M., Sieklucka, B., & Pawlak, K. (2021) · Nutrients · doi:10.3390/nu13030809 · Cited by 31
Yvanoff, C., & Willaert, R. (2022) · Biofabrication · doi:10.1088/1758-5090/ac516e · Cited by 31
Niclot, F. B., Licini, C., Montalbano, G., Fiorilli, S., Mattioli‐Belmonte, M., & Vitale‐Brovarone, C. (2022) · Polymers · doi:10.3390/polym14050857 · Cited by 31
Biomimetic chitosan with biocomposite nanomaterials for bone tissue repair and regeneration
Kim, S., Murugan, S. S., Dalavi, P. A., Gupta, S., Anil, S., Seong, G. H., & Venkatesan, J. (2022) · Beilstein Journal of Nanotechnology · doi:10.3762/bjnano.13.92 · Cited by 31
Necroptosis: A new target for prevention of osteoporosis
Hu, X., Wang, Z., Kong, C., Wang, Y., Zhu, W., Wang, W., Li, Y., Wang, W., & Lu, S. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1032614 · Cited by 31
Biomaterial scaffolds regulate macrophage activity to accelerate bone regeneration
Liu, Z., Zhu, J., Li, Z., Liu, H., & Fu, C. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1140393 · Cited by 31
Yang, Z., Zhang, X., Zhuo, F., Liu, T., Luo, Q.-W., Zheng, Y.-Z., Li, L., Yang, H., Zhang, Y., Wang, Y., et al. (2023) · Advanced Science · doi:10.1002/advs.202206533 · Cited by 31
Antipsychotic-induced bone loss: the role of dopamine, serotonin and adrenergic receptor signalling
Weerasinghe, D. K., Hodge, J. M., Pasco, J. A., Samarasinghe, R. M., Manavi, B. A., & Williams, L. J. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1184550 · Cited by 32
Tommasino, C., Auriemma, G., Sardo, C., Alvarez‐Lorenzo, C., Garofalo, E., Morello, S., Falcone, G., & Aquino, R. P. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.123093 · Cited by 31
Current Evidence on the Effects of Endocrine-Disrupting Chemicals (EDCs) on Bone Growth and Health
Shulhai, A.-M., Palanza, P., & Street, M. E. (2023) · Exposure and Health · doi:10.1007/s12403-023-00607-3 · Cited by 31
Architecture of bone tissue and its adaptation to pathological conditions
Bilgiç, E., Boyacıoğlu, Ö., Gizer, M., Korkusuz, P., & Korkusuz, F. (2020) · Comparative Kinesiology of the Human Body · doi:10.1016/b978-0-12-812162-7.00006-0 · Cited by 30
Sapoznikov, L., & Humphrey, M. (2024) · Cells · doi:10.3390/cells13211806 · Cited by 30
Pathogenic Mechanisms of Myeloma Bone Disease and Possible Roles for NRF2
Yen, C., Hsu, C., Hsiao, S. Y., & Hsiao, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186723 · Cited by 30
Phosphorus-containing compounds regulate mineralization
Du, T., Yang, H., & Niu, X. (2021) · Materials Today Chemistry · doi:10.1016/j.mtchem.2021.100579 · Cited by 30
Bone Mineralization in Electrospun-Based Bone Tissue Engineering
Lim, D. (2022) · Polymers · doi:10.3390/polym14102123 · Cited by 30
Liu, K., Wang, J., Fang, S., Wang, H., Bai, Y., Zhao, Z., Zhu, Q., Wang, C., Chen, G., Jiang, H., et al. (2022) · Materials & Design · doi:10.1016/j.matdes.2022.110856 · Cited by 30
Real and Simulated Microgravity: Focus on Mammalian Extracellular Matrix
Andreeva, E. R., Константиновна, М. Д., Zhidkova, O. V., Zhivodernikov, I. V., Kotov, O. V., & Buravkova, L. B. (2022) · Life · doi:10.3390/life12091343 · Cited by 30
Li, L., Li, H., Wang, Q., Xue, Y., Dai, Y. Q., Dong, Y., Shao, M., & Lyu, F. (2024) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.4c00574 · Cited by 30
Rossi, G. D., Vergani, L. M., & Buccino, F. (2024) · Materials · doi:10.3390/ma17215305 · Cited by 30
Emerging role of circadian rhythm in bone remodeling
Wu, Q.-Y., Wang, J., Tong, X., Chen, J., Wang, B., Miao, Z., Li, X., Ye, J., & Yuan, F. (2018) · Journal of Molecular Medicine · doi:10.1007/s00109-018-1723-9 · Cited by 30
Bone Marrow Niches for Skeletal Progenitor Cells and their Inhabitants in Health and Disease
Herrmann, M., & Jakob, F. J. (2019) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x14666190123161447 · Cited by 30
Zhang, C., Wei, W., Chi, M., Wan, Y., Li, X., Qi, M., & Zhou, Y. (2019) · Journal of Diabetes Research · doi:10.1155/2019/6757428 · Cited by 30
Metadata
- Authors
- Florencio-Silva, R., Sasso, G. R. D. S., Sasso-Cerri, E., Simões, M. J., & Cerri, P. S.
- Affiliations
- Department of Morphology and Genetics, Laboratory of Histology and Structural Biology, Federal University of São Paulo, 04023-900 São Paulo, SP, Brazil
- Universidade Federal de São Paulo (BR)
- Department of Morphology, Laboratory of Histology and Embryology, Dental School, Universidade Estadual Paulista (UNESP), 14801-903 Araraquara, SP, Brazil
- Universidade Estadual Paulista (Unesp) (BR)
- Corresponding author
- Cerri, Paulo Sérgio
- Venue
- BioMed Research International
- Publisher
- Wiley
- Published
- 2015
- Volume
- 2015
- Pages
- 1-17
- ISSN
- 1110-7243 (ISSN-L)
- 2314-6133
- 2314-6141
- PMC
- PMC4515490
- OpenAlex
- W1594526962
- Cited by
- 2,044
- References
- 209
- Citations by year
- 2026: 157 · 2025: 238 · 2024: 265 · 2023: 286 · 2022: 254 · 2021: 241 · 2020: 219 · 2019: 169 · 2018: 110 · 2017: 64 · 2016: 35 · 2015: 5
- FWCI
- 6.92
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- BioMed Research International (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Americanae (AECID Library) (publishedVersion, other-oa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, other-oa)
- Acervo Digital da Universidade Estadual Paulista (Universidade Estadual Paulista) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2010/10391-9, 2012/19428-8, 2012/22666-8)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (2010/10391-9, 2012/19428-8, 2012/22666-8)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (2010/10391-9, 2012/19428-8, 2012/22666-8)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Bone and Dental Protein Studies
- Keywords
- bone remodeling, bone cells, osteoclasts, osteoblasts, osteocytes, bone resorption, bone formation, bone homeostasis, osteocyte apoptosis, osteoporosis, calcitonin, estrogen, growth factors, cytokines, mechanosensing, intercellular communication
- MeSH terms
- Animals, Bone and Bones, Calcification, Physiologic, Cell Communication, Humans, Models, Biological, Osteoblasts, Osteoclasts, Structure-Activity Relationship, Bone Remodeling
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.